India, Oct. 27 -- The shares of this company are one of the leading research and development-driven manufacturers of specialty chemicals are in the spotlight after it rose by 14 per cent in today's session following its Q2 FY27 results, supported by strong growth in its pharmaceutical intermediates segment during the quarter.

With a market capitalisation of Rs. 31,186 cr, the shares of Acutaas Chemicals Ltd were trading at Rs. 3813.35 per share, making an intraday high of Rs. 3,828.90, up by 14% from its previous close of Rs. 3,347.85 per share.

Year-on-Year (YoY) Performance Acutaas Chemicals reported revenue from operations of Rs. 436.9 crore in Q2 FY27, up 42.7% from Rs. 306.2 crore in Q2 FY26. EBITDA surged 84.6% to Rs. 176 crore ...